<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36638922</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6825</ISSN><JournalIssue CitedMedium="Internet"><Volume>151</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of allergy and clinical immunology</Title><ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patients.</ArticleTitle><Pagination><StartPage>1634</StartPage><EndPage>1645</EndPage><MedlinePgn>1634-1645</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaci.2022.12.822</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0091-6749(23)00009-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Allogenic hematopoietic stem cell transplantation (HSCT) and gene therapy (GT) are potentially curative treatments for severe combined immunodeficiency (SCID). Late-onset posttreatment manifestations (such as persistent hepatitis) are not uncommon.</AbstractText><AbstractText Label="OBJECTIVE">We sought to characterize the prevalence and pathophysiology of persistent hepatitis in transplanted SCID patients (SCIDH+) and to evaluate risk factors and treatments.</AbstractText><AbstractText Label="METHODS">We used various techniques (including pathology assessments, metagenomics, single-cell transcriptomics, and cytometry by time of flight) to perform an in-depth study of different tissues from patients in the SCIDH+ group and corresponding asymptomatic similarly transplanted SCID patients without hepatitis (SCIDH-).</AbstractText><AbstractText Label="RESULTS">Eleven patients developed persistent hepatitis (median of 6 years after HSCT or GT). This condition was associated with the chronic detection of enteric viruses (human Aichi virus, norovirus, and sapovirus) in liver and/or stools, which were not found in stools from the SCIDH- group (n = 12). Multiomics analysis identified an expansion of effector memory CD8<sup>+</sup> T cells with high type I and II interferon signatures. Hepatitis was associated with absence of myeloablation during conditioning, split chimerism, and defective B-cell function, representing 25% of the 44 patients with SCID having these characteristics. Partially myeloablative retransplantation or GT of patients with this condition (which we have named as "enteric virus infection associated with hepatitis") led to the reconstitution of T- and B-cell immunity and remission of hepatitis in 5 patients, concomitantly with viral clearance.</AbstractText><AbstractText Label="CONCLUSIONS">Enteric virus infection associated with hepatitis is related to chronic enteric viral infection and immune dysregulation and is an important risk for transplanted SCID patients with defective B-cell function.</AbstractText><CopyrightInformation>Copyright © 2023 American Academy of Allergy, Asthma &amp; Immunology. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Riller</LastName><ForeName>Quentin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fourgeaud</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Microbiology Department, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Pathogen Discovery Laboratory, Institut Pasteur, Université de Paris, Paris, France; Prise en Charge des Anomalies Congénitales et leur Traitement, Unit 7328, Imagine Institute, University of Paris Cité, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruneau</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Pathology Department, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Imagine Institute, INSERM UMR 1163, Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Ravin</LastName><ForeName>Suk See</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fusaro</LastName><ForeName>Mathieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Study Center for Primary Immunodeficiencies, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meriem</LastName><ForeName>Samy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Biostatistics, University of Paris Cité, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magerus</LastName><ForeName>Aude</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luka</LastName><ForeName>Marine</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Labtech Single-Cell@Imagine, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdessalem</LastName><ForeName>Ghaith</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Labtech Single-Cell@Imagine, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lhermitte</LastName><ForeName>Ludovic</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Onco-Haematology, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; the Institut Necker-Enfants Malades (INEM), INSERM UMR 1151, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamet</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Microbiology Department, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; the Institut Necker-Enfants Malades (INEM), INSERM UMR 1151, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Six</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Human Lympho-Hematopoiesis, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnani</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biotherapy, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castelle</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lévy</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lecuit</LastName><ForeName>Mathilde M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fournier</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semeraro</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Clinical Investigation Center, Clinical Research Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Graziella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pediatric Endocrinology, Gynecology, Diabetology, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abid</LastName><ForeName>Hanène</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Microbiology Department, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahlaoui</LastName><ForeName>Nizar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheikh</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pediatric Hematology Oncology Unit, University Hospital of Besançon, Besançon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Florkin</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Immuno-Hémato-Rhumatologie Pédiatrique, Service de Pédiatrie, CHR Citadelle, Liege, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frange</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Microbiology Department, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeziorski</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Infectious Diseases, and Immunology, University of Montpellier, CHU Montpellier, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suarez</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Imagine Institute, INSERM UMR 1163, Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Hematology Department, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarrot-Reynauld</LastName><ForeName>Françoise</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Service de Médecine Interne, Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nouar</LastName><ForeName>Dalila</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Service d'Immunologie Clinique et d'Allergologie, Centre Hospitalier Régional Universitaire, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debray</LastName><ForeName>Dominique</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pediatric Liver Unit, National Reference Center for Rare Diseases, Biliary Atresia and Genetic Cholestasis, Inflammatory Biliary Diseases and Autoimmune Hepatitis, ERN Rare Liver, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacaille</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Gastroenterology-Hepatology-Nutrition Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picard</LastName><ForeName>Capucine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Study Center for Primary Immunodeficiencies, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Laboratory of Lymphocyte Activation and Susceptibility to EBV Infection, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérot</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pathogen Discovery Laboratory, Institut Pasteur, Université de Paris, Paris, France; OIE Collaborating Center for the Detection and Identification in Humans of Emerging Animal Pathogens, Institut Pasteur, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regnault</LastName><ForeName>Béatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Pathogen Discovery Laboratory, Institut Pasteur, Université de Paris, Paris, France; OIE Collaborating Center for the Detection and Identification in Humans of Emerging Animal Pathogens, Institut Pasteur, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Rocha</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Pathogen Discovery Laboratory, Institut Pasteur, Université de Paris, Paris, France; OIE Collaborating Center for the Detection and Identification in Humans of Emerging Animal Pathogens, Institut Pasteur, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Cevins</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, Imagine Institute, INSERM UMR 1163, Paris, France; Artificial Intelligence &amp; Deep Analytics (AIDA) Group, Data &amp; Data Science (DDS), Sanofi R&amp;D, Chilly-Mazarin, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delage</LastName><ForeName>Laure</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérot</LastName><ForeName>Brieuc P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinit</LastName><ForeName>Angélique</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sorbonne Université, UMS037, PASS, Plateforme de Cytométrie de la Pitié-Salpêtrière CyPS, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbone</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Labtech Single-Cell@Imagine, Imagine Institute, INSERM UMR 1163, Paris, France; Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunaud</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchais</LastName><ForeName>Manon</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stolzenberg</LastName><ForeName>Marie-Claude</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asnafi</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Onco-Haematology, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; the Institut Necker-Enfants Malades (INEM), INSERM UMR 1151, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina</LastName><ForeName>Thierry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Pathology Department, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rieux-Laucat</LastName><ForeName>Frédéric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Notarangelo</LastName><ForeName>Luigi D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pittaluga</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Cancer Institute, National Institutes of Health, Bethesda, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jais</LastName><ForeName>Jean Philippe</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Biostatistics, University of Paris Cité, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moshous</LastName><ForeName>Despina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Laboratory of Genome Dynamics in the Immune System, Equipe Labellisée Ligue contre le Cancer, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanche</LastName><ForeName>Stephane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malech</LastName><ForeName>Harry</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eloit</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pathogen Discovery Laboratory, Institut Pasteur, Université de Paris, Paris, France; OIE Collaborating Center for the Detection and Identification in Humans of Emerging Animal Pathogens, Institut Pasteur, Paris, France; Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavazzana</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Onco-Haematology, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Laboratory of Human Lympho-Hematopoiesis, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Collège de France, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ménager</LastName><ForeName>Mickaël M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Labtech Single-Cell@Imagine, Imagine Institute, INSERM UMR 1163, Paris, France; Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, Imagine Institute, INSERM UMR 1163, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neven</LastName><ForeName>Bénédicte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Paris Cité, Paris, France; Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, INSERM UMR 1163, Paris, France; Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address: benedicte.neven@aphp.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZIA AI001222</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol</MedlineTA><NlmUniqueID>1275002</NlmUniqueID><ISSNLinking>0091-6749</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016511" MajorTopicYN="Y">Severe Combined Immunodeficiency</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018380" MajorTopicYN="Y">Hematopoietic Stem Cell Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006505" MajorTopicYN="Y">Hepatitis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B-cell function</Keyword><Keyword MajorTopicYN="N">CD8(+) T cells</Keyword><Keyword MajorTopicYN="N">SCID</Keyword><Keyword MajorTopicYN="N">enteric virus</Keyword><Keyword MajorTopicYN="N">gene therapy</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">transplantation</Keyword></KeywordList><CoiStatement>Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36638922</ArticleId><ArticleId IdType="mid">NIHMS1915167</ArticleId><ArticleId IdType="pmc">PMC10336473</ArticleId><ArticleId IdType="doi">10.1016/j.jaci.2022.12.822</ArticleId><ArticleId IdType="pii">S0091-6749(23)00009-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol 2010;126:602–10.e1–11.</Citation><ArticleIdList><ArticleId IdType="pubmed">20673987</ArticleId></ArticleIdList></Reference><Reference><Citation>Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, et al. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study. Blood 2017;130:2718–27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5746165</ArticleId><ArticleId IdType="pubmed">29021228</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Hacein-Bey-Abina S. Gene therapy for severe combined immunodeficiencies and beyond. J Exp Med 2020;217:e20190607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7041706</ArticleId><ArticleId IdType="pubmed">31826240</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavazzana M, Bushman FD, Miccio A, Andr e-Schmutz I, Six E. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat Rev Drug Discov 2019;18:447–62.</Citation><ArticleIdList><ArticleId IdType="pubmed">30858502</ArticleId></ArticleIdList></Reference><Reference><Citation>Lankester AC, Neven B, Mahlaoui N, von Asmuth EGJ, Courteille V, Alligon M, et al. Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006–2014 European cohort. J Allergy Clin Immunol 2022;149: 1744–54.e8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34718043</ArticleId></ArticleIdList></Reference><Reference><Citation>Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood 2009;113:4114–24.</Citation><ArticleIdList><ArticleId IdType="pubmed">19168787</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968;292:1366–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">4177932</ArticleId></ArticleIdList></Reference><Reference><Citation>Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000–2009. N Engl J Med 2014;371:434–46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4183064</ArticleId><ArticleId IdType="pubmed">25075835</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood 2018;132:1737–49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6202916</ArticleId><ArticleId IdType="pubmed">30154114</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffort C, Le Deist F, Favre M, Caillat-Zucman S, Radford-Weiss I, Debré M, et al. Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common gam-mac cytokine receptor subunit or JAK-3 deficiency. Lancet 2004;363:2051–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">15207958</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd Hamid IJ, Slatter MA, McKendrick F, Pearce MS, Gennery AR. Long-term outcome of hematopoietic stem cell transplantation for IL-2RG/JAK3 SCID: a cohort report. Blood 2017;129:2198–201.</Citation><ArticleIdList><ArticleId IdType="pubmed">28209722</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuetz C, Neven B, Dvorak CC, Leroy S, Ege MJ, Pannicke U, et al. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Blood 2014;123:281–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953035</ArticleId><ArticleId IdType="pubmed">24144642</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan A, Booth C, Brightwell A, Allwood Z, Veys P, Rao K, et al. Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency. Blood 2012;120:3615–24, quiz 3626.</Citation><ArticleIdList><ArticleId IdType="pubmed">22791287</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen ACY, Gyhrs ML, Nielsen LP, Pedersen C, Böttiger B. Gastroenteritis and the novel picornaviruses aichi virus, cosavirus, saffold virus, and salivirus in young children. J Clin Virol 2013;57:239–42.</Citation><ArticleIdList><ArticleId IdType="pubmed">23602437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitajima M, Hata A, Yamashita T, Haramoto E, Minagawa H, Katayama H. Development of a reverse transcription-quantitative PCR system for detection and gen-otyping of aichi viruses in clinical and environmental samples. Appl Environ Microbiol 2013;79:3952–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3697579</ArticleId><ArticleId IdType="pubmed">23603673</ArticleId></ArticleIdList></Reference><Reference><Citation>Touzot F, Dal-Cortivo L, Verkarre V, Lim A, Crucis-Armengaud A, Moshous D, et al. Massive expansion of maternal T cells in response to EBV infection in a patient with SCID-Xl. Blood 2012;120:1957–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22936741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2010;363:355–64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957288</ArticleId><ArticleId IdType="pubmed">20660403</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrette F, Surh CD. IL-7 signaling and CD127 receptor regulation in the control of T cell homeostasis. Semin Immunol 2012;24:209–17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3367861</ArticleId><ArticleId IdType="pubmed">22551764</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SY, Zhang Z, Fu JL, Kang FB, Xu XS, Nie WM, et al. Progressive CD127 down-regulation correlates with increased apoptosis of CD8 T cells during chronic HIV-1 infection. Eur J Immunol 2009;39:1425–34.</Citation><ArticleIdList><ArticleId IdType="pubmed">19350559</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ravin SS, Wu X, Moir S, Anaya-O’Brien S, Kwatemaa N, Littel P, et al. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Sci Transl Med 2016;8:335ra57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5557273</ArticleId><ArticleId IdType="pubmed">27099176</ArticleId></ArticleIdList></Reference><Reference><Citation>Labarta-Bajo L, Nilsen SP, Humphrey G, Schwartz T, Sanders K, Swafford A, et al. Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection. J Exp Med 2020;217:e20192276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953738</ArticleId><ArticleId IdType="pubmed">32880630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearden D, Collett M, Quan PL, Costa-Carvalho BT, Sullivan KE. Enteroviruses in X-linked agammaglobulinemia: update on epidemiology and therapy. J Allergy Clin Immunol Pract 2016;4:1059–65.</Citation><ArticleIdList><ArticleId IdType="pubmed">26883540</ArticleId></ArticleIdList></Reference><Reference><Citation>Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, Crispe IN, et al. Kupffer cell-dependent hepatitis occurs during influenza infection. Am J Pathol 2006;168:1169–78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1606556</ArticleId><ArticleId IdType="pubmed">16565492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciol G, Moens L, Payne K, Wollants E, Mekahli D, Levtchenko E, et al. Chronic Aichi virus infection in a patient with X-linked agammaglobulinemia. J Clin Immunol 2018;38:748–52.</Citation><ArticleIdList><ArticleId IdType="pubmed">30311057</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyts I, Bucciol G, Jansen K, Wollants E, Breuer J. Aichivirus: an emerging pathogen in patients with primary and secondary B-cell deficiency [published online ahead of print November 30, 2022]. J Clin Immunol. 10.1007/s10875-022-01410-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-022-01410-6</ArticleId><ArticleId IdType="pubmed">36449139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekassy Z, Ehinger M, Pronk LN, Pronk CJ, Bekassy Z, Ehinger M, et al. Immunologic control of disseminated Aichi virus infection in X-linked agammaglobulinemia by transplantation of TCR αβ-depleted haploidentical hematopoietic cells. J Clin Immunol 2022;42:1401–4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9253251</ArticleId><ArticleId IdType="pubmed">35788939</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes-Santos CJ, Koh C, Rai A, Sacco K, Marciano BE, Kleiner DE, et al. Nodular regenerative hyperplasia in X-linked agammaglobulinemia: an underesti-mated and severe complication. J Allergy Clin Immunol 2022;149:400–9.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8633079</ArticleId><ArticleId IdType="pubmed">34087243</ArticleId></ArticleIdList></Reference><Reference><Citation>Frange P, Touzot F, Debré M, Héritier S, Leruez-Ville M, Cros G, et al. Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies. J Infect Dis 2012;206:1269–74.</Citation><ArticleIdList><ArticleId IdType="pubmed">22872736</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima H, Watanabe T, Miyazaki T, Takeuchi M, Honda Y, Shimada N, et al. Acute liver dysfunction in the course of norovirus gastroenteritis. Case Rep Gastroenterol 2012;6:69–73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3304080</ArticleId><ArticleId IdType="pubmed">22423242</ArticleId></ArticleIdList></Reference><Reference><Citation>Khayat AA, Telega GW. Persistent elevation of aminotransferases in liver transplant in association with chronic norovirus infection. Clin Mol Hepatol 2019;25: 408–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6933126</ArticleId><ArticleId IdType="pubmed">31062535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Jones MK, Hickman D, Han S, Reeves W, Karst SM. Norovirus antagonism of B cell antigen presentation results in impaired control of acute infection. Mucosal Immunol 2016;9:1559–70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5035161</ArticleId><ArticleId IdType="pubmed">27007673</ArticleId></ArticleIdList></Reference><Reference><Citation>Upasani V, Rodenhuis-Zybert I, Cantaert T. Antibody-independent functions of B cells during viral infections. PLoS Pathog 2021;17:e1009708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8297758</ArticleId><ArticleId IdType="pubmed">34293057</ArticleId></ArticleIdList></Reference><Reference><Citation>Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW. STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003;299:1575–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12624267</ArticleId></ArticleIdList></Reference><Reference><Citation>Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW. Antibody is critical for the clearance of murine norovirus infection. J Virol 2008;82: 6610–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2447077</ArticleId><ArticleId IdType="pubmed">18417579</ArticleId></ArticleIdList></Reference><Reference><Citation>Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Ebbo M, et al. Evidence of innate lymphoid cell redundancy in humans. Nat Immunol 2016;17:1291–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5074366</ArticleId><ArticleId IdType="pubmed">27618553</ArticleId></ArticleIdList></Reference><Reference><Citation>Afridi SQ, Usman Z, Donakonda S, Wettengel JM, Velkov S, Beck R, et al. Prolonged norovirus infections correlate to quasispecies evolution resulting in struc-tural changes of surface-exposed epitopes. iScience 2021;24:102802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324856</ArticleId><ArticleId IdType="pubmed">34355146</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>